---
title: A Trial on Laparoscopic Appendectomy Versus Single Port Appendectomy
nct_id: NCT01348464
overall_status: COMPLETED
sponsor: Gachon University Gil Medical Center
study_type: OBSERVATIONAL
primary_condition: Acute Appendicitis
countries: South Korea
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01348464.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01348464"
ct_last_update_post_date: 2012-04-04
last_seen_at: "2026-05-12T07:23:26.085Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# A Trial on Laparoscopic Appendectomy Versus Single Port Appendectomy

**Official Title:** Transumbilical Single Port Laparoscopic Appendectomy Versus Conventional Laparoscopic Appendectomy in Adult Patients: A Prospective Randomized Control Study

**NCT ID:** [NCT01348464](https://clinicaltrials.gov/study/NCT01348464)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 150
- **Lead Sponsor:** Gachon University Gil Medical Center
- **Conditions:** Acute Appendicitis
- **Start Date:** 2010-03
- **Completion Date:** 2011-12
- **CT.gov Last Update:** 2012-04-04

## Brief Summary

The aim of this study is to compare patients who undergone single-port access laparoscopic appendectomy to those who underwent conventional three-port laparoscopic appendectomy (TPLA) in a prospective randomized trial

## Detailed Description

* primary objective

  1\. complication rate
* secondary objectives

  1. satisfaction rate
  2. pain scale difference

## Eligibility

- **Minimum age:** 5 Years
- **Maximum age:** 85 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* age 5\~85 years
* any patient diagnosed with acute appendicitis on appendix sonography or abdominopelvic CT
* Patient performance status(PS) with greater than 80 or more on Karnofsky PS
* Give written informed consent prior to study specific screening procedures, with the understanding that the patient has the right to withdraw from the study at any time, without prejudice.

Exclusion Criteria:

* Pregnant or lactating
* Serious uncontrolled intercurrent infections, or other serious uncontrolled concomitant disease
* History of Previous cytotoxic chemotherapy, radiotherapy or immunotherapy, for the currently treated cancer
* Clinically significant (i.e. active) cardiac disease e.g. symptomatic coronary artery disease, New York Heart Association (NYHA) grade II or greater congestive heart failure or serious cardiac arrhythmia requiring medication or myocardial infarction within the last 12 months.
```

## Arms

- **lifestyle, wound satisfaction** — single site access three site access for appendectomy

## Interventions

- **single port appendectomy, three port appendectomy** (PROCEDURE) — visual analog scale. questionnaire on wound satisfaction

## Primary Outcomes

- **Complication rate** _(time frame: participants will be followed for the duration of hospital stay, an expected average of 24 weeks)_ — observe complication caused by both procedures

## Secondary Outcomes

- **patient satisfaction** _(time frame: participants will be followed for the duration of hospital stay, an expected average of 24 weeks)_

## Locations (1)

- Gachon Univ., Gil Medical Center, Incheon, South Korea

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.gachon univ., gil medical center|incheon||south korea` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01348464.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01348464*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*